Digna Biotech is a biotech company focused on developing clinical therapeutic candidates through partnerships. Its pipeline includes CT-1 for kidney transplant and liver surgery, disitertide for scleroderma, and products for gene therapy, hepatitis C, liver diseases, oncology, and more. The company partners with research centers and universities and is headquartered in Spain. This report provides details on Digna's pipeline products, clinical trials, and company information to help evaluate investment and partnership opportunities.

1. Digna Biotech, S.L. - Product Pipeline Analysis
June, 9, 2014: Company Profiles and Conferences presents a Company Report on "Digna
Biotech, S.L. - Product Pipeline Analysis", who provides key information about the company, its
major products and brands.
Summary
Digna Biotech, S.L. (Digna) is a biotechnology company. It focuses on the development and
commercialization of robust clinical therapeutic candidates through partnerships with
pharmaceutical companies. The pipeline portfolio of the company includes Clinical Products:
CT-1 for kidney transplant and liver surgery, disitertide for cutaneous manifestation of
Scleroderma, AAV5-PBGD for gene therapy acute intermittent prophyria and IFNa5 Receptor
for hepatitis C virus infection; and preclinical products including DB-036 for gene therapy for
liver cirrhosis, DB-055 for blood loss, DB-017 for Ischemic stroke and DB-029.01 for oncology
among others. It focuses on therapeutic areas such as oncology, liver diseases, dermatology,
cardiovascular, autoimmune diseases and ophthalmology. It’s scientific, educational, and clinical
partners are Center for Applied Medical Research (CIMA), the Center for Applied
Pharmacobiology Research (CIFA), a number of Schools of the University of Navarra, and the
University Clinic of Navarra. Digna is headquartered in Pamplona, Navarra, Spain.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio
of pipeline products. The report provides key information about the company, its major products
and brands.
The report enhances decision making capabilities and help to create effective counter strategies
to gain competitive advantage.
Scope:
 The report reviews detailed company profile with information on business description,
key company facts, major products and services, key competitors, key employees,
locations and subsidiaries and recent developments
 The report analyzes all pipeline products in development for the company Digna Biotech,
S.L.
 The report provides pipeline analysis on all pipeline products of the company (by
equipment type, by indication, by development stage, and by trial status)
 The report covers detailed information on each pipeline product with information on
pipeline territory, stage of development, device class, regulatory path, indication(s),
application(s) and estimated launch date

2.  The report provides detailed description of products in development, technical
specification and functions
 The report also covers ongoing clinical trials (wherever applicable) with information on
trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and
end date.
Reasons to Buy:
 Develop business strategies by understanding the trends and developments driving the
medical devices pipeline and technology landscape
 Design and develop your product development, marketing and sales strategies by
understanding the competitor portfolio
 To formulate effective R&D strategies
 Develop market-entry and market expansion strategies
 Exploit in-licensing and out-licensing opportunities by identifying products, most likely
to ensure a robust return
 Plan mergers and acquisitions effectively by identifying key players of the most
promising pipeline
 Identify emerging players with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
 Develop competition strategies by identifying the status and likely launch of the
competitors’ pipeline products through review of the clinical trials, stage and of
development, etc
 Identify, understand and capitalize the next high-value products that your competitor
would add in its portfolio
For more information kindly visit:
http://www.companyprofilesandconferences.com/researchindex/Medical-Devices-c32/Digna-
Biotech-SL-Product-Pipeline-Analysis.html
Related link: http://www.companyprofilesandconferences.com/researchindex/Medical-
Devices.asp
About Company Profiles and Conferences
Search thousands of company profiles, SWOT analysis reports and company financials. Search
by industry sector, or simply search all company profiles by company name.
companyprofilesandconferences.com contains one of the world's largest collections of company
insight and company profiles from leading global market report publishers and analysts. Global

3. brands rely on companyprofilesandconferences.com for their strategic company insight and
company profile needs.
Contact us at:
Company Profiles And Conferences
Mob +919223375060 / 919223767111
Fax : +91 22 27810778
E-mail : info@companyprofilesandconferences.com
Website : www.companyprofilesandconferences.com